Source: StreetInsider

Press Release: Travere Therapeutics : Travere Therapeutics to Report First Quarter 2025 Financial Results

SAN DIEGO--(BUSINESS WIRE)-- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report first quarter 2025 financial results on Thursday, May 1, 2025, after the close of the U.S....

Read full article »
Travere Therapeutics's Competitors | Travere Therapeutics's News | Travere Therapeutics's Financials
Stay up-to-date with the latest news on Travere Therapeutics
Annual Revenue
$100-500M
Employees
250-500
Eric Dube's photo - President & CEO of Travere Therapeutics

President & CEO

Eric Dube

CEO Approval Rating

84/100

Read more
Stay up-to-date with the latest news on Travere Therapeutics